StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.71−0.32 (-7.94%)

Close on Nov 13, 2026Market cap $154.33MP/E 1.1Yield 6.74%

Earnings

Oramed Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Oramed Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2025ended Sep 30, 2025Oct 24, 2025after the close–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Oramed Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Oramed Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Oramed Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE DATED JANUARY 13, 2026
    News
  2. PRESS RELEASE DATED JANUARY 7, 2026
    News
  3. PRESS RELEASE DATED NOVEMBER 17, 2025.
    Results
  4. SHAREHOLDER LETTER, DATED OCTOBER 23, 2025
    Results
  5. PRESS RELEASE, DATED APRIL 28, 2025 (FURNISHED PURSUANT TO ITEM 7.01)
    Update
  6. PRESS RELEASE, DATED FEBRUARY 11, 2025 (FURNISHED PURSUANT TO ITEM 7.01)
    Update
  7. PRESS RELEASE DATED OCTOBER 7, 2024
    Update
  8. PRESS RELEASE DATED FEBRUARY 20, 2024
    News
  9. PRESS RELEASE, DATED SEPTEMBER 21, 2023
    Update
  10. SECURITIES TRANSFER TERM SHEET, DATED SEPTEMBER 11, 2023 AMONG SCILEX HOLDING COMPANY, SORRENTO THERAPEUTICS, INC. AND ORAMED PHARMACEUTICALS INC
    News
  11. NOTE TERM SHEET, DATED SEPTEMBER 11, 2023 AMONG THE COMPANY, SCILEX HOLDING COMPANY, AND SORRENTO THERAPEUTICS, INC
    News
  12. TERM SHEET DATED AUGUST 4, 2023, BY AND AMONG ORAMED PHARMACEUTICALS INC. AND SORRENTO THERAPEUTICS, INC
    News
  13. INVESTOR PRESENTATION DATED DECEMBER 12, 2022
    Update
  14. PRESS RELEASE DATED NOVEMBER 10, 2022
    Results
  15. PRESS RELEASE DATED JULY 7, 2022
    News

See a number that looks wrong?